dr. opyrchal: do you have a go-to regimen for patients with er /pr /her2-negative disease?
Published 10 years ago • 45 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
0:25
dr. opyrchal: if a patient’s tumor is er /pr , how does that impact your treatment decisions?
-
1:32
dr. opyrchal: what are the next treatment steps for kim?
-
0:26
dr. opyrchal: how do you decide what chemo should be given in pts who have relapsed within 6 mos?
-
0:33
dr. opyrchal: how do you decide when chemotherapy should be administered?
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
0:35
dr. opyrchal: how do you determine if a patient is resistant to a taxane or anthracyclines?
-
2:48
dr. rivera: how do you decide between hormone therapies in patients with er /pr tumors?
-
5:00
adjuvant endocrine therapy used to treat er her2- breast cancer
-
7:08
selective oestrogen receptor degraders as treatment for er positive/her2 negative advanced/metas...
-
0:57
dr. soliman: if a patient’s tumor is er /pr , how does that impact your treatment decisions?
-
28:03
triple negative breast cancer - o'regan
-
1:33
dr. denduluri on treatment for er /her2- breast cancer
-
4:10
treatment overview: er-positive breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
2:56
what prognosis for er negative pr positive and her2 negative breast cancer survivor | onco power
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
4:14
er degrader safe, with signs of antitumour activity against er-positive breast cancer